TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12626901

Group type: EXPERIMENTAL
Intervention: Rubber band ligation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Stapled hemorrhoidectomy
Number of subjects: 55
Study: 10679130

Group type: EXPERIMENTAL
Intervention: Comprehensive infection control program including educational program and single-branded germicidal products for 12 months.
Number of subjects: 890

Group type: COMPARATOR
Intervention: Existing infection control policies and procedures (Control group).
Number of subjects: 890
Study: 9081269

Group type: EXPERIMENTAL
Intervention: 7.6% carbohydrate-electrolyte (CE) solution
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (artificially flavored and colored water)
Number of subjects: 19
Study: 8373876

Group type: EXPERIMENTAL
Intervention: Intralipid (20% of long chain triglycerides)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lipofundina (10% each of long and medium-chain triglycerides)
Number of subjects: 0
Study: 2431461

Group type: EXPERIMENTAL
Intervention: Transurethral electroresection of the prostate (TURP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bladder neck incision (BNI)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both TURP and BNI
Number of subjects: 24
Study: 29972213

Group type: EXPERIMENTAL
Intervention: Auraptene enriched test juice (6.0 mg/day)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo juice
Number of subjects: 84
Study: 26630412

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Non-Motivational Interviewing (non-MI)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Transdiagnostic group CBT (for both MI and non-MI)
Number of subjects: 39
Study: 24473387

Group type: EXPERIMENTAL
Intervention: Standard continuous blood purification with heparin anticoagulation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Continuous blood purification without anticoagulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Heparin group
Number of subjects: 16
Study: 22392567

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low plasma concentration of DEX (0.04 ng/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High plasma concentration of DEX (0.08 ng/mL)
Number of subjects: 0
Study: 20160215

Group type: EXPERIMENTAL
Intervention: Patients with poor insight
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Increasing neuropsychiatric symptoms
Number of subjects: 321
Study: 17698336

Group type: EXPERIMENTAL
Intervention: General anesthesia (n=17)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Spinal anesthesia (n=20)
Number of subjects: 37
Study: 15917042

Group type: EXPERIMENTAL
Intervention: Free fruit
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Paid fruit
Number of subjects: 795

Group type: COMPARATOR
Intervention: No fruit
Number of subjects: 795
Study: 12841994

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 701
Study: 10587413

Group type: EXPERIMENTAL
Intervention: Montelukast sodium therapy for 4 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Montelukast sodium therapy (post-treatment)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline ENO levels in asthmatic children
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Montelukast sodium therapy
Number of subjects: 12
Study: 8692528

Group type: EXPERIMENTAL
Intervention: IL-2 preoperative therapy (18.10(6) IU/day subcutaneously for 3 consecutive days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: IL-2 preoperative therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no IL-2 preoperative therapy)
Number of subjects: 50
Study: 1748776

Group type: EXPERIMENTAL
Intervention: Extradural buprenorphine 0.3 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extradural pentazocine 30 mg
Number of subjects: 0
Study: 6632727

Group type: EXPERIMENTAL
Intervention: Dimethylbiguanide (DMB) in doses of between 1 and 3 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dimethylbiguanide (DMB)
Number of subjects: 0
Study: 31699072

Group type: EXPERIMENTAL
Intervention: Nebulized 3% hypertonic saline for 3 days (HS3d group)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Nebulized 3% hypertonic saline for 1 day followed by 0.9% normal saline for 2 days (HS1d group)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups (HS1d and HS3d)
Number of subjects: 116
Study: 28622048

Group type: EXPERIMENTAL
Intervention: TCZ‐SC 162 mg qw monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: TCZ‐SC 162 mg q2w monotherapy
Number of subjects: 0
Study: 26164058

Group type: EXPERIMENTAL
Intervention: Patellar tendon (PT)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Quadruple-stranded hamstring tendon (HT)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Double bundle using hamstring tendon (DB)
Number of subjects: 330
Study: 25315686

Group type: COMPARATOR
Intervention: Powerade (Coca Cola Ltd); 129 kJ.100 mL(‐1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sustagen Sport (Nestle); 417 kJ.100 mL(‐1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Soy milk (273 kJ.100 mL(‐1))
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cow's milk (286 kJ.100 mL(‐1))
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sustagen Sport
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Soy milk
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cow's milk
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Powerade
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All milk trials
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All beverages
Number of subjects: 15
Study: 22846245

Group type: EXPERIMENTAL
Intervention: Psychological distress as a mediator
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Economic stressors
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Past-month drinking and problematic drinking
Number of subjects: 663
Study: 19076245

Group type: EXPERIMENTAL
Intervention: Daily hygiene with a soft toothbrush and toothpaste (G1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Daily hygiene with a soft toothbrush and toothpaste plus immersion in sodium hypochlorite 0.5% for 20 min once a week (G2)
Number of subjects: 20
Study: 17499654

Group type: EXPERIMENTAL
Intervention: Ketamine (0.2 mg x kg(‐1) intravenous over 10 minutes)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (isotonic sodium chloride solution)
Number of subjects: 73
Study: 15211021

Group type: EXPERIMENTAL
Intervention: Bicycle ergometry exercise protocol
Number of subjects: 100
Study: 11980113

Group type: EXPERIMENTAL
Intervention: Ventolin nebulizer (2.5 mg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Berodual (0.25 mg ipratropium bromide and 0.5 mg phenoterol)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Atrovent (0.5 mg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Berotek (1.0 mg by nebulizer Pulmo-Aide 56501)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Combination of beta 2‐adrenomimetic with atrovent
Number of subjects: 78
Study: 9531685

Group type: EXPERIMENTAL
Intervention: Sennosides (1 ml/kg, max 75 ml of syrup containing 2.0 mg/ml sennoside A and B)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Lavage solution only
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Sennosides
Number of subjects: 171
Study: 9098257

Group type: EXPERIMENTAL
Intervention: Aminocaproic acid (100 mg/kg every 4 hours; maximum 30 g daily)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Aminocaproic acid
Number of subjects: 94
Study: 2523658

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isradipine 5.0 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Isradipine 7.5 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 329946

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy for six 12-week courses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuation of maintenance chemotherapy for a further six 12-week courses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic irradiation to cranium and spine combined with intrathecal methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylactic treatment
Number of subjects: 0
Study: 30054228

Group type: EXPERIMENTAL
Intervention: Pulsed field gel electrophoresis (PFGE) analysis with XbaI
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Pulsed field gel electrophoresis (PFGE) analysis with BlnI
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Whole genome sequencing (WGS) analysis
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Single nucleotide polymorphism (SNP) analysis
Number of subjects: 88
Study: 28818607

Group type: COMPARATOR
Intervention: TTFC ≤5 minutes
Number of subjects: 18729

Group type: EXPERIMENTAL
Intervention: TTFC ≥60 minutes
Number of subjects: 18729

Group type: EXPERIMENTAL
Intervention: Adding TTFC to lung cancer incidence model
Number of subjects: 18729
Study: 26188663

Group type: EXPERIMENTAL
Intervention: High methadone dose (100 mg/day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Low methadone dose (10-25 mg/day)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (cigarette smoking-matched)
Number of subjects: 7
Study: 23679146

Group type: EXPERIMENTAL
Intervention: Nutritional Counseling Group (NCG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Ad Libitum Group (ALG)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (NCG and ALG)
Number of subjects: 39
Study: 21469942

Group type: EXPERIMENTAL
Intervention: 1 mL syringe
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 3 mL syringe
Number of subjects: 223

Group type: COMPARATOR
Intervention: 10 mL syringe
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Various syringe sizes (1, 3, 5, 10, 20, 60 mL)
Number of subjects: 223
Study: 19644851

Group type: EXPERIMENTAL
Intervention: High-dose D-penicillamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose D-penicillamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human relaxin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (for relaxin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral bovine type I collagen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (for collagen)
Number of subjects: 0
Study: 17473738

Group type: EXPERIMENTAL
Intervention: Laser suture lysis (LSL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Releasable sutures
Number of subjects: 48
Study: 16045374

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 322
Study: 11728835

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate at low plasma levels (0.1-0.3 ng/ml)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate at medium plasma levels (0.3-0.6 ng/ml)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate at high plasma levels (0.6-1.0 ng/ml)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 31
Study: 9468782

Group type: EXPERIMENTAL
Intervention: Video tape
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Picture book
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both video tape and picture book
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (unrelated materials)
Number of subjects: 80
Study: 7657402

Group type: EXPERIMENTAL
Intervention: Clinically-guided self-help (CGSH) program plus standard treatment (methadone maintenance plus individual counseling)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Didactic lecture program plus standard treatment
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 3
Study: 2762658

Group type: EXPERIMENTAL
Intervention: Indobufen (400 mg/die)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 40
Study: 805623

Group type: EXPERIMENTAL
Intervention: IgG anti‐K (13‐14 mug)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no IgG anti‐K)
Number of subjects: 62
Study: 31659597

Group type: EXPERIMENTAL
Intervention: Preoperative systemic immune-inflammation index (SII) calculated as (neutrophil) × (platelet)/(lymphocyte) with a cutoff value of 843; evaluated for cancer-specific survival (CSS) and overall survival (OS).
Number of subjects: 191
Study: 30904909

Group type: EXPERIMENTAL
Intervention: Endobronchial autologous blood plus thrombin patch (ABP)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Bronchial occlusion using silicone spigots (BOS)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Chest tube‐attached water‐seal drainage (CTD)
Number of subjects: 150
Study: 29025485

Group type: EXPERIMENTAL
Intervention: Household intervention
Number of subjects: 3061

Group type: COMPARATOR
Intervention: Non-household intervention
Number of subjects: 3061
Study: 25542552

Group type: EXPERIMENTAL
Intervention: Engaging in advance care planning (ACP) using online decision aid ('Making Your Wishes Known')
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Engaging in ACP (Intervention group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intervention group (Engaging in ACP)
Number of subjects: 200
Study: 23636085

Group type: EXPERIMENTAL
Intervention: Whole-body vibration treatment during 17 sessions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham group performing the same exercises without vibration
Number of subjects: 20
Study: 21612611

Group type: EXPERIMENTAL
Intervention: K‐134 50 mg
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: K‐134 100 mg
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: K‐134 25 mg
Number of subjects: 199
Study: 19386794

Group type: EXPERIMENTAL
Intervention: Simulator-based driving training
Number of subjects: 83

Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 83
Study: 15674004

Group type: EXPERIMENTAL
Intervention: Reiki treatment by experienced Reiki practitioner
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo treatment by a person with no knowledge of Reiki
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment (rest only)
Number of subjects: 45
Study: 10334756

Group type: EXPERIMENTAL
Intervention: individual‐cluster trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cluster‐cluster trials
Number of subjects: 0
Study: 7484044

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl 100 micrograms.h‐1
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo system
Number of subjects: 24
Study: 2258442

Group type: EXPERIMENTAL
Intervention: Plain waterbed
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Continuously oscillating waterbed
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intermittently oscillating waterbed
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (incubator mattress)
Number of subjects: 52
Study: 7029297

Group type: EXPERIMENTAL
Intervention: Vincristine, dactinomycin, and cyclophosphamide (VAC) for 2 years after excision of localized tumor (group I)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Vincristine combined with dactinomycin with postoperative irradiation (group II)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy regimens, 'pulse' VAC alone or VAC combined with adriamycin followed by irradiation (group III)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Patients with metastatic disease at diagnosis (group IV)
Number of subjects: 780
Study: 31651889

Group type: EXPERIMENTAL
Intervention: High-dose HT047 (750 mg 3 times a day)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Low-dose HT047 (500 mg 3 times a day)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 28830927

Group type: EXPERIMENTAL
Intervention: Counseling intervention (4 sessions)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 13
Study: 25329433

Group type: EXPERIMENTAL
Intervention: 8-week exercise intervention (light-to-moderate-intensity aerobic and resistance exercises, mainly leg press, 3 sessions per week)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4-week detraining period
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard-care (control) group
Number of subjects: 20
Study: 24354616

Group type: EXPERIMENTAL
Intervention: Intradermal PRP after FCL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Topical PRP after FCL
Number of subjects: 30

Group type: COMPARATOR
Intervention: FCL alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: ID saline after FCL
Number of subjects: 30
Study: 21894411

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation weaning protocol using spontaneous breathing trial
Number of subjects: 36

Group type: COMPARATOR
Intervention: Mechanical ventilation weaning without a standardized protocol (Control)
Number of subjects: 36
Study: 19301380

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication treatment (standard protocol)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No specific treatment (control group)
Number of subjects: 55
Study: 17133405

Group type: EXPERIMENTAL
Intervention: Decitabine 100 mg/m(2) per course every 4 weeks in 3 different schedules: 1) 20 mg/m(2) intravenously daily x 5, 2) 20 mg/m(2) subcutaneously daily x 5, and 3) 10 mg/m(2) intravenously daily x 10
Number of subjects: 115
Study: 15170007

Group type: EXPERIMENTAL
Intervention: Isotretinoin, 0.5 mg/kg daily for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11789362

Group type: EXPERIMENTAL
Intervention: Thiazide 50 mg/day
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Thiazide and potassium citrate
Number of subjects: 150

Group type: COMPARATOR
Intervention: No treatment (Control Group A)
Number of subjects: 150
Study: 9440763

Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 0
Study: 8283158

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 2046

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2046
Study: 29080299

Group type: EXPERIMENTAL
Intervention: Telbivudine-based therapy
Number of subjects: 534
Study: 26631773

Group type: EXPERIMENTAL
Intervention: Prosthetic grafts
Number of subjects: 100

Group type: COMPARATOR
Intervention: Autologous veins
Number of subjects: 100
Study: 25241369

Group type: EXPERIMENTAL
Intervention: CO2 as distension media
Number of subjects: 392

Group type: COMPARATOR
Intervention: Normal saline as distension media
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: VAS>3 group
Number of subjects: 392

Group type: COMPARATOR
Intervention: VAS≤3 group
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Multivariate analysis
Number of subjects: 392
Study: 24325953

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane catheter delivering intermittent local anesthetic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patient‐controlled anesthesia device delivering intravenous opioids (Control)
Number of subjects: 0
Study: 20963271

Group type: EXPERIMENTAL
Intervention: Greater social-environmental support for disease management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less depressive symptomatology
Number of subjects: 0
Study: 19789522

Group type: EXPERIMENTAL
Intervention: Propofol - Remifentanil
Number of subjects: 33

Group type: COMPARATOR
Intervention: Propofol - Alfentanil
Number of subjects: 33
Study: 16461376

Group type: EXPERIMENTAL
Intervention: Handgrip (HG) exercise at 70% of maximum voluntary contraction
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Handgrip (HG) exercise at 50% of maximum voluntary contraction
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Quadriceps contraction (QC) exercise
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Post-HG circulatory responses
Number of subjects: 20
Study: 15876979

Group type: EXPERIMENTAL
Intervention: Dihydropyridine calcium antagonists (nitrendipine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antihypertensive regimens (various classes)
Number of subjects: 0
Study: 11905711

Group type: EXPERIMENTAL
Intervention: Preoperative (neoadjuvant) medical therapy
Number of subjects: 0
Study: 9137021

Group type: EXPERIMENTAL
Intervention: Biojector (needleless injection system)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Needle injections
Number of subjects: 74
Study: 8194308

Group type: EXPERIMENTAL
Intervention: RMNP2 program for non-parametric analysis of repeated measures
Number of subjects: 0
Study: 3796171

Group type: EXPERIMENTAL
Intervention: Single dose amoxicillin (100 mg/kg) followed by placebo every 8 hours for 10 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: 10-day course of amoxicillin (40 mg/kg/D)
Number of subjects: 17
Study: 31986338

Group type: EXPERIMENTAL
Intervention: Maternal exposure to PM10 during the three months preconception
Number of subjects: 10686

Group type: EXPERIMENTAL
Intervention: Maternal exposure to PM10 during the first trimester
Number of subjects: 10686

Group type: EXPERIMENTAL
Intervention: Maternal exposure to PM10 from the third month before pregnancy to the third month after pregnancy
Number of subjects: 10686
Study: 29499393

Group type: EXPERIMENTAL
Intervention: Ecological momentary assessments (EMA)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CHAID classification of EMAs into six levels of risk
Number of subjects: 43
Study: 26494768

Group type: EXPERIMENTAL
Intervention: Mechanical Diagnosis and Therapy (MDT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Back School
Number of subjects: 140
Study: 26582405

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid for 5 consecutive days
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo for 5 consecutive days
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300